Literature DB >> 10192797

Interphotoreceptor retinoid-binding protein (IRBP) is rapidly cleared from the Xenopus interphotoreceptor matrix.

L L Cunningham1, L Yang, F Gonzalez-fernandez.   

Abstract

The interphotoreceptor matrix (IPM) is a highly-organized extracellular matrix critical to retinal development and function. Although the concentrations of its components are carefully regulated, little is known about the mechanisms of this regulation. Interphotoreceptor retinoid-binding protein (IRBP) is the most abundant soluble protein component of the IPM. Although its rate of clearance is thought to be an important factor regulating the concentration of IRBP within the IPM, no study has measured the rate of its extracellular turnover. Here we determine the rate of turnover of matrix IRBP in Xenopus. The rate of IRBP turnover was estimated by measuring the loss of radioactivity from protein labeled by a single injection of a radiolabeled protein precursor. To provide an estimate of the rate of IRBP turnover, we have examined the following issues: (1) Quantitative extraction of IRBP from the IPM for biochemical analysis. (2) Routes of delivery of radiolabeled precursor to achieve a pulse label in vivo. (3) Selection of labeled precursor in order to minimize reutilization of radiolabel. Using Western blot analysis, immunoprecipitation and immuno-electron microscopy, we found that IRBP can be quantitatively extracted from the IPM by a simple saline wash. IRBP was radiolabeled by systemic or intravitreal injection of either [35S]methionine or carboxyl-terminal labeled [1-14C]leucine. The specific activity of matrix IRBP was determined by either phosphorimaging or fluorography of Coomassie blue-stained SDS-polyacrylamide gels. Intravitreal injection of tracer was more effective than systemic delivery in achieving a pulse of radiolabel to the retina. This may be due to intravitreal injection allowing the body to act as a 'sink' for radiolabeled amino acid. When radiolabeled precursor was delivered by intravitreal injection, the calculated half-life of matrix IRBP using [35S]methionine was 25. 6+/-0.82 hr; in contrast, it was 10.7+/-2.9 hr using [1-14C]leucine. The faster apparent IRBP turnover using [1-14C]leucine is interpreted in context of the early decarboxylation of leucine during its degradation. Our results demonstrate rapid turnover of IRBP in the Xenopus IPM in vivo and suggest that the IPM is a dynamic structure undergoing continuous renewal. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10192797     DOI: 10.1006/exer.1998.0633

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  5 in total

1.  The interphotoreceptor retinoid-binding protein (IRBP) of the chicken (Gallus gallus domesticus).

Authors:  Deborah L Stenkamp; John L Calderwood; Ellen E Van Niel; Lawrence M Daniels; Federico Gonzalez-Fernandez
Journal:  Mol Vis       Date:  2005-09-30       Impact factor: 2.367

2.  Thiol-dependent antioxidant activity of interphotoreceptor retinoid-binding protein.

Authors:  Federico Gonzalez-Fernandez; Dongjin Sung; Karen M Haswell; Andrew Tsin; Debashis Ghosh
Journal:  Exp Eye Res       Date:  2014-01-12       Impact factor: 3.467

3.  Interphotoreceptor retinoid binding protein; myths and mysteries.

Authors:  Federico Gonzalez-Fernandez
Journal:  J Ophthalmic Vis Res       Date:  2012-01

4.  Purification of the full-length Xenopus interphotoreceptor retinoid binding protein and growth of diffraction-quality crystals.

Authors:  Debashis Ghosh; Jennifer B Griswold; Thomas Bevilacqua; Federico Gonzalez-Fernandez
Journal:  Mol Vis       Date:  2007-12-13       Impact factor: 2.367

5.  Module structure of interphotoreceptor retinoid-binding protein (IRBP) may provide bases for its complex role in the visual cycle - structure/function study of Xenopus IRBP.

Authors:  Federico Gonzalez-Fernandez; Claxton A Baer; Debashis Ghosh
Journal:  BMC Biochem       Date:  2007-08-04       Impact factor: 4.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.